黏蛋白与肝内胆管癌的研究进展
摘要
肝内胆管癌是原发于胆管上皮细胞的恶性肿瘤,其恶性程度高,预后不佳。而黏蛋白基因的异常表达与胆管癌的发生,进展和预后有着密切的关系。
出处
《湘南学院学报（医学版）》
2011年第3期77-79,共3页
Journal of Xiangnan University（Medical Sciences）
参考文献2
-
1Jyoti Nautiyal,Arun K Rishi,Adhip PN Majumdar.Emerging therapies in gastrointestinal cancers[J].World Journal of Gastroenterology,2006,12(46):7440-7450. 被引量：4
-
2Chanchai Boonla,Banchob Sripa,Peti Thuwajit,Ubon Cha-On,Anucha Puapairoj,Masanao Miwa,Sopit Wongkham.MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma[J].World Journal of Gastroenterology,2005,11(32):4939-4946. 被引量：6
二级参考文献124
-
1Apa Juntavee,Banchob Sripa,Ake Pugkhem,Narong Khuntikeo,Sopit Wongkham.Expression of sialyl Lewis^a relates to poor prognosis in cholangiocarcinoma[J].World Journal of Gastroenterology,2005,11(2):249-254. 被引量：3
-
2[1]Schottenfeld D.Gastrointestinal cancer:epidemiology.In Gastrointestinal Oncology:Principles and Practice.Kelsen DP,Daly JM,Levin B,eds.Philadelphia:Lippincott,Williams & Wilkins,2002:3-24
-
3[2]Parkin DM,Pisani P,Ferlay J.Global cancer statistics.CA Cancer J Clin 1999; 49:33-64
-
4[3]Levin B,Brooks D,Smith RA,Stone A.Emerging technologies in screening for colorectal cancer:CT colonography,immunochemical fecal occult blood tests,and stool screening using molecular markers.CA cancer J Clin 2003; 53:44-55
-
5[4]Burch PA,Block M,Schroeder G,Kugler JW,Sargent DJ,Braich TA,Mailliard JA,Michalak JC,Hatfield AK,Wright K,Kuross SA.Phase Ⅲ evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer:a North Central Cancer Treatment Group study.Clin Cancer Res 2000; 6:3486-3492
-
6[5]Risch HA.Etiology of pancreatic cancer,with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity.J Natl Cancer Inst 2003; 95:948-960
-
7[6]Schally AV,Szepeshazi K,Nagy A,Comaru-Schally AM,Halmos G.New approaches to therapy of cancers of the stomach,colon and pancreas based on peptide analogs.Cell Mol Life Sci 2004; 61:1042-1068
-
8[7]Gill S,Thomas RR,Goldberg RM.New targeted therapies in gastrointestinal cancers.Curr Treat Options Oncol 2003; 4:393-403
-
9[8]Berlin J.New directions in the treatment of advanced colorectal cancer.Oncology (Williston Park) 2001; 15:27-30
-
10[9]Herbst RS,Shin DM.Monoclonal antibodies to target epidermal growth factor receptor-positive tumors:a new paradigm for cancer therapy.Cancer 2002; 94:1593-1611
共引文献8
-
1Manuela Gatto,Domenico Alvaro.New insights on cholangiocarcinoma[J].World Journal of Gastrointestinal Oncology,2010,2(3):136-145. 被引量：5
-
2高志强,丁志强,陈勇军,李晓云,罗强,陈忠.胰腺癌组织黏蛋白MUC_1表达的意义[J].世界华人消化杂志,2006,14(9):923-926. 被引量：8
-
3Olga V Smirnova,Tatiana Yu Ostroukhova,Roman L Bogorad.JAK-STAT pathway in carcinogenesis:Is it relevant to cholangiocarcinoma progression?[J].World Journal of Gastroenterology,2007,13(48):6478-6491. 被引量：14
-
4赵时梅,朱雄增,纪元,侯君.黏液素在肝内胆管癌中的表达[J].中华病理学杂志,2008,37(11):749-753. 被引量：3
-
5Alphonse E Sirica.Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma[J].World Journal of Gastroenterology,2008,14(46):7033-7058. 被引量：35
-
6董娜娜,段晓峰,张倜,李慧锴,周洪渊,李强.103例肝内胆管癌临床病理及诊治分析[J].中国肿瘤临床,2012,29(6):340-342. 被引量：13
-
7刘少琼,杨芳,禹正杨.姜黄素对大肠癌细胞抑制作用Notch信号通路的研究进展[J].湖南中医杂志,2013,29(12):163-168. 被引量：2
-
8邹依宁,朱坤,张欣,韩晶,张荔莉,高峰,张小垒,黄玉凤,宿杰阿克苏,纪元.肝内胆管癌患者根治性切除术后基于病理指标生存预测模型的构建与评估[J].中华肝胆外科杂志,2022,28(9):667-672.
-
1王谨,李升平,王俊,彭启全,徐立,梁哲昭,林国和.大鼠肝内胆管癌发生发展与调节性T细胞动态变化的相关性[J].中华实验外科杂志,2009(12):1594-1596. 被引量：2
-
2匡铭,梁平.肝内胆管癌发生过程中微血管变化[J].重庆医学,2005,34(12):1849-1850.
-
3张东兵,刘璞.经胆道灌注化疗对肝内胆管癌大鼠的疗效[J].肝胆胰外科杂志,2009,21(3):187-190. 被引量：3
-
4陈巧彬,陈琅.NGF、NaHS对哮喘大鼠气道炎症的调节作用[J].安徽医科大学学报,2011,46(12):1242-1245. 被引量：8
-
5张世杰,郎振为,王欣欣,吕福东.联合应用磷脂酰肌醇蛋白多糖-3(GPC-3)和细胞角蛋白-19(CK-19)免疫组化检测在肝细胞肝癌诊断和鉴别诊断中的价值[J].首都医科大学学报,2011,32(5):653-657. 被引量：9
-
6朱泽斌,叶林森,郑朝旭.PI3K/Akt信号通路在胆管癌中的作用[J].中华肝脏外科手术学电子杂志,2016,5(5):330-333. 被引量：3
-
7刘剑波,张珍祥,徐永健,邢丽华,张惠兰.糖皮质激素对IL-13诱导的小鼠肺组织黏蛋白基因Muc5ac表达的影响[J].中国免疫学杂志,2006,22(8):764-767. 被引量：1
-
8洪书剑,顾国胜,任建安,李宁,黎介寿.肠内营养对长期禁食肠瘘患者肠黏膜上皮内淋巴细胞及黏液屏障功能的研究[J].中华胃肠外科杂志,2006,9(6):527-529. 被引量：22
